Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Research Progress of Metal Anticancer Drugs
by
Ai, Jun
, Aodeng, Gerile
, Ga, Lu
, Bai, Yun
, Hai, Wenfeng
in
Antimitotic agents
/ Antineoplastic agents
/ Breast cancer
/ Cancer
/ Cancer therapies
/ Cell cycle
/ Cell death
/ Cell growth
/ Chemotherapy
/ Drug resistance
/ Drug therapy
/ FDA approval
/ Flavonoids
/ gold anticancer drugs
/ iridium anticancer drugs
/ Lung cancer
/ Medical prognosis
/ Medical research
/ Mitochondrial DNA
/ Neurotoxicity
/ Oxidative stress
/ Patients
/ platinum anticancer drugs
/ R&D
/ Research & development
/ Review
/ ruthenium anticancer drugs
/ Toxicity
/ Tumors
/ Zoledronic acid
2023
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Research Progress of Metal Anticancer Drugs
by
Ai, Jun
, Aodeng, Gerile
, Ga, Lu
, Bai, Yun
, Hai, Wenfeng
in
Antimitotic agents
/ Antineoplastic agents
/ Breast cancer
/ Cancer
/ Cancer therapies
/ Cell cycle
/ Cell death
/ Cell growth
/ Chemotherapy
/ Drug resistance
/ Drug therapy
/ FDA approval
/ Flavonoids
/ gold anticancer drugs
/ iridium anticancer drugs
/ Lung cancer
/ Medical prognosis
/ Medical research
/ Mitochondrial DNA
/ Neurotoxicity
/ Oxidative stress
/ Patients
/ platinum anticancer drugs
/ R&D
/ Research & development
/ Review
/ ruthenium anticancer drugs
/ Toxicity
/ Tumors
/ Zoledronic acid
2023
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Research Progress of Metal Anticancer Drugs
by
Ai, Jun
, Aodeng, Gerile
, Ga, Lu
, Bai, Yun
, Hai, Wenfeng
in
Antimitotic agents
/ Antineoplastic agents
/ Breast cancer
/ Cancer
/ Cancer therapies
/ Cell cycle
/ Cell death
/ Cell growth
/ Chemotherapy
/ Drug resistance
/ Drug therapy
/ FDA approval
/ Flavonoids
/ gold anticancer drugs
/ iridium anticancer drugs
/ Lung cancer
/ Medical prognosis
/ Medical research
/ Mitochondrial DNA
/ Neurotoxicity
/ Oxidative stress
/ Patients
/ platinum anticancer drugs
/ R&D
/ Research & development
/ Review
/ ruthenium anticancer drugs
/ Toxicity
/ Tumors
/ Zoledronic acid
2023
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Research Progress of Metal Anticancer Drugs
2023
Request Book From Autostore
and Choose the Collection Method
Overview
Cancer treatments, including traditional chemotherapy, have failed to cure human malignancies. The main reasons for the failure of these treatments are the inevitable drug resistance and serious side effects. In clinical treatment, only 5 percent of the 50 percent of cancer patients who are able to receive conventional chemotherapy survive. Because of these factors, being able to develop a drug and treatment that can target only cancer cells without affecting normal cells remains a big challenge. Since the special properties of cisplatin in the treatment of malignant tumors were accidentally discovered in the last century, metal anticancer drugs have become a research hotspot. Metal anticancer drugs have unique pharmaceutical properties, such as ruthenium metal drugs with their high selectivity, low toxicity, easy absorption by tumor tissue, excretion, and so on. In recent years, efficient and low-toxicity metal antitumor complexes have been synthesized. In this paper, the scientific literature on platinum (Pt), ruthenium (Ru), iridium (Ir), gold (Au), and other anticancer complexes was reviewed by referring to a large amount of relevant literature at home and abroad.
This website uses cookies to ensure you get the best experience on our website.